LAUSR

Purpose: To investigate the combined effect of celecoxib and glucosamine sulfate on inflammatory factors and oxidative stress indicators in patients with knee osteoarthritis (KOA). Methods: Patients were randomly assigned to two groups of 60 patients each: control group and study group. The control group received celecoxib at a dose of 200 mg/kg/day, while the study group received glucosamine sulfate (500 mg/kg) in addition to celecoxib, thrice a day. Treatment in both groups lasted 8 weeks. The serum levels of tumor necrosis factor α (TNF-α), interleukin-1 (IL-1), prostaglandin-2 (PGE2), malondialdehyde (MDA), and activity of superoxide dismutase (SOD) were assayed before and after treatment. Visual analogue scale (VAS), osteoarthritis index, Lysholm knee score scale (LKSS), and adverse reactions were also evaluated. Results: After treatment, total effectiveness was significantly higher in the study group (91.33 %) than in control group (71.67 %, p < 0.05). Serum TNF-α, IL-1 and PGE2 were significantly lesser in the glucosamine sulfate-treated patients than in control group ( p < 0.05). The activity of SOD was significantly higher in glucosamine sulfate-exposed patients than control patients ( p < 0.05). On the other hand, VAS and WOMAC scores were markedly lower in patients given glucosamine sulfate than in control patients ( p < 0.05). Conclusion: The combination of celecoxib with glucosamine sulfate effectively reduces immune inflammatory response, oxidative stress damage, and joint pain associated with KOA. Keywords: Celecoxib, Glucosamine sulfate, Osteoarthritis, Inflammatory factors, Oxidative stress